Overview
Mattia Facchetti practices practicing medicine in Brescia, Italy.
Facchetti is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Activated PI3K Delta Syndrome (APDS) and Primary Immunodeficiency (PID).
They are actively involved in clinical research, co-authoring 13 peer reviewed articles.
Locations
Brescia, Italy
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mattia Facchetti
Is Mattia Facchetti a top-rated expert for Activated PI3K Delta Syndrome (APDS)?
MediFind is an objective health platform that identifies experts based on real-world data. Mattia Facchetti is classified as an Advanced expert for Activated PI3K Delta Syndrome (APDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mattia Facchetti participate in research or clinical trials?
Yes. Mattia Facchetti has published 13 articles and abstracts on conditions like Activated PI3K Delta Syndrome (APDS). You can view a list of Mattia Facchetti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Activated PI3K Delta Syndrome (APDS)
- Experienced
- Primary Immunodeficiency (PID)Facchetti isExperienced. Learn about Primary Immunodeficiency (PID).